Herpes zoster, inactivated vaccine (2027)
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security AgencycontractFind a Tender ↗Ref ocds-h6vhtk-066916Procurement Act 2023pending
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
1 awarded
Published
13 Mar 2026
Description
The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.
Scope
- Reference
- CM/PHV/27/C384964
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
31 Mar 2027
Contract end
31 Mar 2029
Awarded to